The retina is an integral part of the central nervous system which has a conserved architecture among vertebrates. The neurons of the neural retina are organized in layers, with the most distant for the incident light, the photoreceptor layer in close contact with the retinal pigmented epithelium (RPE) at the back of the eye. Rod and cone photorecptors are light sensitive cells that rely on opsin sensitive molecules for photon capture. These molecules are enclosed on disk membranes of a cellular structure, located on the outer segment of the photoreceptor which points in the direction of the RPE1. This structure, which is most often affected very early in cases of photoreceptor degenerations, is renewed at the rate of 10% every day. The so called inner layer contains most of the other neurons that compute the signal received from the photoreceptors, the bipolar, amacrine and horizontal cells as well as the ganglion cells. These latter with their axons form a beam which is the optic nerve. This layering is so conserved that biologists have used the term displaced amacrine cells when the cells are found outside the inner plexiform layer2. Layers of neurons are distributed within an armature of radial Müller glial cells. Bipolar cells link photoreceptors to ganglion cells. They are located between the external plexiform layer and the inner plexiform layer. The ganglion cells form the inner plexiform layer in connection with the bipolar cells. The amacrin cells are named as association cells located in the inner plexiform layer between the bipolar cells and ganglion cells. The outer plexiform layer contains horizontal cells. This unique arrangement of neuronal layers of the central nervous system permits the isolation of the photoreceptor layer from the inner cell layer by slicing the flat-mounted retina using a vibratome.
Originally, this technique was used to isolate photoreceptors for transplantation in the eye of the rd1 mouse, a model of human retinitis pigmentosa (RP)3. The rd1 mouse carries a recessive mutation in the Pde6b gene which encodes for the rod-specific phosphodiesterase beta subunit. Recessive mutations of this gene result in RP in humans4. After rod photoreceptors have degenerated, the patient loses night vision, and surprisingly cone photoreceptors, which do not express the mutated gene, degenerate as a second step. Because the cones are required for color vision and visual acuity, the patients become progressively blind and an effective treatment for the disease has not yet developed. By grafting photoreceptor layer from a wild-type mouse the cone degeneration of the host mouse is delayed3,5. The rods lost in the rod-cone degenerative model could not be replaced by a transplant because the synaptic connection between rods and bipolar cells can only be obtained at a specific stage of retinal development, marked by the onset of Nrl expression6. The layer of photoreceptors is introduced by surgery in the sub-retinal space of the rod-less rd1 retina, between the RPE and the outer retina corresponding to only 3% of the remaining photoreceptors, the cones. Two weeks after surgery, 40% of the cones from the animal transplanted with a normal photoreceptor layer survived as compared to the animal transplanted with a normal layer of inner retinal cells, or to the sham-operated animal. The topography of cone survival, spread-out over the entire surface of the mutated retina located at the position of the grafted tissue indicates that the protective effect is due to a diffusible molecule7.
Next, we used a co-culture system as well as conditioned culture media to validate the fact that the protective effect relies on the secretion of a protein by rods8,9. We hypothesize that this protein will be expressed continuously and specifically by rods and that their death during the first phase of the disease will trigger secondary cone degeneration by the loss of a protective signal from rods in a non-cell autonomous manner10. Because of the importance of cone mediated central vision in primates this putative protein will be a highly relevant therapeutic tool for RP. Preserving the cones in RP would theoretically prevent a total of 1.5 million patients worldwide to become blind11. We have used a high content screening approach and a cone-enriched culture model to identify a cDNA encoding Rod-derived Cone Viability Factor (RdCVF) from a retinal cDNA library12. RdCVF is the spliced product of the NXNL1 gene which, interestingly is homologous to the gene encoding for thioredoxin proteins involved in redox homeostasis13. The second spliced product of the gene, RdCVFL is an enzyme that protects its target, the TAU protein against oxidative damage14. Administration of RdCVF prevents the secondary degeneration of cones and the loss of their visual function in a recessive, and dominant model of RP12,15. This demonstrates two important aspects of this innovative therapeutic strategy16. First, it can be applied in most of the RP cases in a gene-independent manner. Second, contrary to the competing factor CNTF, RdCVF survival is associated with the maintenance of visual function17. The absence of functional effect may explain the reason of the absence of clinical benefit of the administration of CNTF to RP patients18. RdCVF is most likely one of the important survival signal between rods and cones since cone rescue in vitro is inhibited by RdCVF immunodepletion12. In addition, the disruption of the rod-derived cone viability gene leads to photoreceptor dysfunction and susceptibility to oxidative stress19.
The use of photoreceptor layer is at the origin of identification of RdCVF and of a novel redox signal involved in neurodegenerative diseases20. This manuscript describes the protocol used to isolate and culture cells from the photoreceptor layer to characterize the activity of RdCVF. The photoreceptors can be maintained in culture for 5 to 7 days21. This technique can also be used to study the expression of photoreceptor specific genes.